Effect of botulinum toxin on Raynaud's phenomenon in patients with systemic sclerosis

Not Applicable

• Conditions: Raynaud' s phenomenon

• Registration Number: JPRN-UMIN000024135
• Lead Sponsor: Gunma University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-09-23
• Study Completion: 2017-07-12
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 2

Inclusion Criteria

Not provided

Exclusion Criteria

Patients under the age 16, with the pregnancy or having the past medical histories with BTX were excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The change in severity of RP, including the frequency, pain, color and duration, by the Raynaud's condition score at 4 weeks after treatment compared with the baseline.

Secondary Outcome Measures

Name	Time	Method
The change in severity of RP, including the frequency, pain, color and duration, by the Raynaud's condition score at 8, 12, 16 weeks after treatment compared with the baseline.